In our current study, when the pretreatment evaluations of the MDD group cases were compared with the first evaluations of the control group cases, there was no significant difference among FSH, E2, and AMH levels, while LH levels in the MDD group were significantly lower. The gene discussed is PLOD1; the disease is major depressive disorder.